The UCD Conway Institute of Biomolecular & Biomedical Research is a new multidisciplinary research institute established on the main Belfield campus of University College Dublin (UCD). The research programme at the Conway Institute focuses on biological molecules; examining how individual molecules contribute to the normal operation of cells and organs and how this can be disrupted by disease. The knowledge gained improves our understanding of the causes and effects of disease. This leads to simpler, more reliable diagnostic tests and treatments. Achievements by Conway researchers highlighted in the 2003 annual report included publicly funded grant income in excess of €20 million and 264 publications in high quality scientific journals. A Board of Management under the chairmanship of Mr. Denis Brosnan, former Chair & C.E.O. of Kerry Group plc, operates the Conway Institute. The 11,200m2 facility accommodates a total of 400 researchers including postgraduate students and postdoctoral fellows. The innovative building design contributes to promoting interaction between research groups by virtue of its large, open-plan research wings and central spines of shared facilities.